Biohaven (BHVN) Director John W. Childs Receives Stock Option Award

What Happened
John W. Childs, a director of Biohaven Ltd. (BHVN), was granted 68,693 derivative shares (an equity award/option) on April 28, 2026. The filing reports an acquisition price of $0.00 (award/grant), so no cash purchase was made. This is a compensation-style grant rather than a market buy or sale.

Key Details

• Transaction date: 2026-04-28; Form 4 filed 2026-04-30.
• Transaction type: Award/Grant (derivative securities) — 68,693 shares @ $0.00.
• Shares owned after transaction: not specified in the filing.
• Vesting: The options vest in full on the earlier of (a) April 28, 2027 or (b) the date of the 2027 Annual Meeting of Shareholders, subject to continuous service. (See footnote.)
• Timeliness: Filed two days after the transaction date — appears timely under standard reporting windows.
• No indication this was an exercise or a cashless sale; it is a grant of future equity.

Context
Grants to directors are commonly part of compensation or retention programs and do not by themselves indicate buying or selling sentiment. Because this is a derivative award with a future vesting date, any economic benefit depends on future service and Biohaven’s stock performance at vesting.